Decrease expression of peptide–MHC class I complex (thereby sensitizing tumor to NK cells)Increase expression of FAS and the TRAIL receptor DR5Induce NOXA-mediated enhancement of mitochondrial SMAC release (thereby increasing sensitivity to T cells). The gene discussed is FAS; the disease is neoplasm.